Program Overview |
 |
||
Please read the following information about this educational activity before accessing the presentations using links located at the bottom of this page. |
|||
| Release Date: May 28, 2009 | Expiration Date: May 27, 2010 | ||
Accreditation for Pharmacists |
|||
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The program provides 2.5 hours (0.25 CEUs) of continuing education credit (program number 204-000-09-405-H01P).
Methods and Format
This is an online activity consisting of audio and slides for three presentations, a post-test, and an activity evaluation tool. Participants must view all presentations, take the activity post-test, and complete the course evaluation to receive continuing education credit. A minimum score of 70% is required on the test for credit to be awarded, and participants may print their official statements of continuing education credit immediately. The estimated time to complete this activity is 2.5 hours. This activity is provided free of charge.
Target Audience
This continuing education activity was planned to meet the needs of pharmacists in a variety of health care settings and the managed care environment, including large and small hospitals, ambulatory clinics, outpatient pharmacies, health plans, academia, consulting groups, medical groups, and employer/purchasing groups. This activity would be particularly beneficial for those who are interested in cardiology, medication therapy management services, and pharmacy benefits.
Activity Content
Click here to view an overview of the activity content.
Learning Objectives
After participating in this knowledge-based educational activity, participants should be able to
- Describe the etiology of atrial fibrillation (AF) and trends related to its prevalence in the United States.
- Use patient characteristics to predict an individual's risk for developing AF and subsequent risk for stroke.
- Describe how medications are used to address the three primary goals of pharmacotherapy in patients with AF.
- Compare and contrast the efficacy and safety of established and investigational therapies for AF.
- Given a patient case, describe a regimen for AF based on patient-specific factors.
- Identify important pharmacoeconomic considerations in treating AF.
- Describe at least three ways in which managed care pharmacists can streamline care and improve health care outcomes for patients with AF.
Faculty
Cynthia A. Sanoski, Pharm.D., FCCP, BCPS
Program Chair
Associate Professor and Chair
Department of Pharmacy Practice
Jefferson School of Pharmacy
Thomas Jefferson University
Philadelphia, Pennsylvania
Samuel G. Johnson, Pharm.D., BCPS (AQ-Cardiology), CACP
Clinical Pharmacy Specialist in Cardiology
Kaiser Permanente Colorado
Denver, Colorado
James S. Kalus, Pharm.D., BCPS (AQ-Cardiology)
Senior Manager, Patient Care Services
Department of Pharmacy Services
Henry Ford Hospital
Detroit, Michigan
Disclosure Statements
In accordance with the Accreditation Council for Continuing Medical Education's and the Accreditation Council for Pharmacy Education's Standards for Commercial Support, ASHP Advantage requires that all individuals involved in the development of program content disclose their relevant financial relationships and that conflicts of interest be identified and resolved prior to delivery of the activity.
The faculty and planners report the following relationships:
Cynthia A. Sanoski, Pharm.D., FCCP, BCPS
Dr. Sanoski declares that she has no relationships pertinent to this activity.
Samuel G. Johnson, Pharm.D., BCPS (AQ-Cardiology), CACP
Dr. Johnson declares that he has no relationships pertinent to this activity.
James S. Kalus, Pharm.D., BCPS (AQ-Cardiology)
Dr. Kalus declares that he has no relationships pertinent to this activity.
Carla J. Brink, M.S., R.Ph.
Ms. Brink declares that she has no relationships pertinent to this activity.
Susan R. Dombrowski, M.S., R.Ph.
Ms. Dombrowski declares that she has no relationships pertinent to this activity.
This activity is supported by an educational grant from sanofi-aventis U.S.
Launch Presentation*
-
Atrial Fibrillation: Clinical, Economic, and Quality of Life Challenges (30 minutes)
Cynthia A. Sanoski, Pharm.D., FCCP, BCPS, Program Chair -
Emerging Options to Improve Clinical Outcomes in Patients with Atrial Fibrillation (60 minutes)
James S. Kalus, Pharm.D., BCPS (AQ-Cardiology) -
Managing Atrial Fibrillation in the New Paradigm: Opportunities for Managed Care Pharmacists to Improve Health Care Outcomes (50 minutes)
Samuel G. Johnson, Pharm.D., BCPS (AQ-Cardiology), CACP
*Allow additional time to complete the post-test and evaluation.
Download Post-Test
Click here to print the post-test for your reference. Please note that to be eligible for continuing education credit, you must go to the ASHP Learning Center and complete the test online.
This program is planned and conducted by ASHP Advantage.
